Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1976-10-1
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0030-6096
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
21
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
119-26
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:821030-9,10-Dimethyl-1,2-benzanthracene,
pubmed-meshheading:821030-Adenocarcinoma,
pubmed-meshheading:821030-Animals,
pubmed-meshheading:821030-Benz(a)Anthracenes,
pubmed-meshheading:821030-Male,
pubmed-meshheading:821030-Neoplasms, Experimental,
pubmed-meshheading:821030-Pancreatic Neoplasms,
pubmed-meshheading:821030-Rats
|
pubmed:year |
1975
|
pubmed:articleTitle |
Pancreatic cancer developing in Sprague-Dawley rats after local application of 7,12-dimethyl benzanthracene (DMBA).
|
pubmed:publicationType |
Journal Article
|